Literature DB >> 8989820

Structure and function studies of factor XIIIa by x-ray crystallography.

V C Yee1, I Le Trong, P D Bishop, L C Pedersen, R E Stenkamp, D C Teller.   

Abstract

The three-dimensional structures of several forms of the factor XIII A subunit have been determined using single crystal x-ray diffraction methods. Our crystallographic studies have provided the first detailed structural view of the factor XIII A subunit and information that is useful for understanding transglutaminase function. We have identified a conserved Cys314-His373-Asp396 catalytic triad of residues in the active site of the molecule and a number of other conserved residues that may play important roles as well. The calcium and strontium structures have revealed several conserved acidic residues (Asp438, Glu485, and Glu490) involved in ion binding. We have also been able to use our crystal structures as scaffolds to model the possible structural effects of missense mutations that have been identified in factor XIII-deficient patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989820     DOI: 10.1055/s-2007-999035

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  6 in total

1.  Identification of a novel mutation combination in factor XIII deficiency: genetic update to the first reported case in the United States.

Authors:  Amy Halverstadt; Sean Walsh; Stephen M Roth; Robert E Ferrell; James M Hagberg
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

2.  Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.

Authors:  Bijan Ahvazi; Hee Chul Kim; Sun-Ho Kee; Zoltan Nemes; Peter M Steinert
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

3.  Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.

Authors:  Boris A Anokhin; William L Dean; Kerrie A Smith; Matthew J Flick; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  FEBS J       Date:  2019-08-28       Impact factor: 5.542

Review 4.  New insight into transglutaminase 2 and link to neurodegenerative diseases.

Authors:  Boram Min; Kwang Chul Chung
Journal:  BMB Rep       Date:  2018-01       Impact factor: 4.778

5.  The role of β-barrels 1 and 2 in the enzymatic activity of factor XIII A-subunit.

Authors:  E L Hethershaw; P J Adamson; K A Smith; W N Goldsberry; R J Pease; S E Radford; P J Grant; R A S Ariëns; M C Maurer; H Philippou
Journal:  J Thromb Haemost       Date:  2018-05-27       Impact factor: 5.824

Review 6.  Current understanding in diagnosis and management of factor XIII deficiency.

Authors:  M Naderi; A Dorgalaleh; Sh Tabibian; Sh Alizadeh; P Eshghi; Gh Solaimani
Journal:  Iran J Ped Hematol Oncol       Date:  2013-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.